The reactions of hydropersulfides (RSSH) with myoglobin

Copyright © 2020 Elsevier Inc. All rights reserved..

Hydropersulfides are reported to be good biological reductants, superior to thiols and akin to selenols. As such, they have been previously shown to reduce metalloproteins such as ferric myoglobin and ferric cytochrome c to their ferrous forms under conditions where little or no reduction from corresponding thiols is observed. Not surprisingly, the reduction of ferric myoglobin to ferrous myoglobin under aerobic conditions results in the generation of oxymyoglobin (dioxygen bound ferrous myoglobin). Previous studies have demonstrated that oxymyoglobin can also act as an oxidant with highly reducing species such as hydroxylamine and ascorbate. Considering the reducing properties of hydropersulfides, it is possible that they can also react with oxymyoglobin similarly to hydroxylamine or ascorbate. Herein, this reaction is examined and indeed hydropersulfides are found to react with oxymyoglobin similarly to other reducing species leading to a fleeting ferric myoglobin which is rapidly reduced to the ferrous form also by hydropersulfide.

Medienart:

E-Artikel

Erscheinungsjahr:

2020

Erschienen:

2020

Enthalten in:

Zur Gesamtaufnahme - volume:687

Enthalten in:

Archives of biochemistry and biophysics - 687(2020) vom: 15. Juli, Seite 108391

Sprache:

Englisch

Beteiligte Personen:

Álvarez, Lucía [VerfasserIn]
Suarez Vega, Valeria [VerfasserIn]
McGinity, Christopher [VerfasserIn]
Khodade, Vinayak S [VerfasserIn]
Toscano, John P [VerfasserIn]
Nagy, Peter [VerfasserIn]
Lin, Joseph [VerfasserIn]
Works, Carmen [VerfasserIn]
Fukuto, Jon M [VerfasserIn]

Links:

Volltext

Themen:

2FP81O2L9Z
Ascorbic Acid
GNN1DV99GX
Hydrogen sulfide
Hydropersulfides
Hydroxylamine
Journal Article
Myoglobin
Oxygen
Oxymyoglobin
PQ6CK8PD0R
Penicillamine
Persulfides
Polysulfides
Research Support, Non-U.S. Gov't
Research Support, U.S. Gov't, Non-P.H.S.
S88TT14065
Sulfheme
Sulfides

Anmerkungen:

Date Completed 02.10.2020

Date Revised 02.10.2020

published: Print-Electronic

Citation Status MEDLINE

doi:

10.1016/j.abb.2020.108391

funding:

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

NLM309443571